scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0387-7604(96)00056-3 |
P698 | PubMed publication ID | 9071488 |
P2093 | author name string | M Kobayashi | |
T Yamamoto | |||
K Saito | |||
E Kondo | |||
M Osawa | |||
C Toyoda | |||
P2860 | cites work | Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33 | Q28257920 |
Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus | Q28291726 | ||
Neuronal migration, with special reference to developing human brain: a review | Q39880021 | ||
Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. | Q40792342 | ||
Destruction of meningeal cells over the newborn hamster cerebellum with 6-hydroxydopamine prevents foliation and lamination in the rostral cerebellum | Q41245657 | ||
Abnormal localization of laminin subunits in muscular dystrophies | Q42503064 | ||
Cortical dysplasia in a 23-week fetus with Fukuyama congenital muscular dystrophy (FCMD). | Q42517399 | ||
Meningeal cells are involved in foliation, lamination, and neurogenesis of the cerebellum: evidence from 6-hydroxydopamine-induced destruction of meningeal cells | Q42527917 | ||
Congenital muscular dystrophy as a disease of the central nervous system | Q48379271 | ||
Meningeal cells influence cerebellar development over a critical period | Q48411302 | ||
Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type). | Q48647852 | ||
Prenatal diagnosis of Fukuyama type congenital muscular dystrophy by polymorphism analysis | Q48830604 | ||
Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations | Q70859118 | ||
Marginal glioneural heterotopias of the central nervous system | Q72659453 | ||
P433 | issue | 1 | |
P921 | main subject | Fukuyama congenital muscular dystrophy | Q1955377 |
P304 | page(s) | 35-42 | |
P577 | publication date | 1997-01-01 | |
P1433 | published in | Brain and Development | Q15750896 |
P1476 | title | Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy | |
P478 | volume | 19 |
Q29347528 | A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss. |
Q36810193 | Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy |
Q30942094 | Cerebellar cortical dysplasia: MRI aspects and significance |
Q43542175 | Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy |
Q43818931 | Deficiency of a 180-kDa extracellular matrix protein in Fukuyama type congenital muscular dystrophy skeletal muscle |
Q50465175 | Developmental changes of mast cell populations in the cerebral meninges of the rat. |
Q48393339 | Essential role of alpha 6 integrins in cortical and retinal lamination |
Q42479480 | Fukuyama-type congenital muscular dystrophy: close relation between changes in the muscle basal lamina and plasma membrane |
Q48277389 | Immature astrocytes in Fukuyama congenital muscular dystrophy: an immunohistochemical study |
Q48224285 | Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study |
Q41854949 | Roles of fukutin, the gene responsible for fukuyama-type congenital muscular dystrophy, in neurons: possible involvement in synaptic function and neuronal migration |
Q28139770 | The Fukuyama congenital muscular dystrophy story |
Q48867792 | The role of Glial-Pial barrier lesions and impaired vascularization in anomalous formation of cortical convolutions |
Q60300741 | The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy |
Q52036416 | [MR imaging in mental retardation] |
Search more.